University of Louisville School of Medicine Hematology and Medical Oncology

Topics

• CAR-T cell therapy research 64
• Multiple Myeloma Research and Treatments 42
• Cancer, Hypoxia, and Metabolism 32
• Cancer Immunotherapy and Biomarkers 25
• Head and Neck Cancer Studies 18
• Hematopoietic Stem Cell Transplantation 14
• Venous Thromboembolism Diagnosis and Management 14
• Acute Myeloid Leukemia Research 12
• Polyomavirus and related diseases 12
• Lung Cancer Diagnosis and Treatment 11
• Lung Cancer Treatments and Mutations 11
• Brain Metastases and Treatment 10

Most cited

1. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.

   JAMA oncology · 2023 · 399 citations · Stephanie Wagner

2. Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.

   The New England journal of medicine · 2026 · 63 citations · Hamza Hashmi

3. Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.

   The New England journal of medicine · 2022 · 422 citations · Hamza Hashmi

4. Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal.

   The New England journal of medicine · 2023 · 119 citations · Sucheta Telang

5. Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 271 citations · Hamza Hashmi

6. Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 80 citations · Mehran Yusuf

7. Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis.

   Journal of neurointerventional surgery · 2021 · 204 citations · Quan Do

8. Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 257 citations · Jason Chesney